VIRxSYS Corporation

Patent Applications and Registrations

Patent applications and USPTO patent grants for VIRxSYS Corporation.The latest application filed is for "trans-complementing, replication deficient lentiviral vectors and methods for making and using them".

Company Profile

0.10.12

VIRxSYS Corporation - South Portland ME US
VIRXSYS CORPORATION - Gaithersburg MD US
VIRXSYS CORPORATION - GAITHERBURG MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Trans-complementing, replication deficient lentiviral vectors and methods for making and using them App 20150030627 - Lu; Xiaobin ; et al.	2015-01-29
Compositions And Methods For Inducing Apoptosis App 20150025127 - McGarrity; Gerard John	2015-01-22
Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing Grant 8,883,753 - Puttaraju , et al. November 11, 2	2014-11-11
Expression Of Apoai And Variants Thereof Using Spliceosome Mediated Rna Trans-splicing App 20120046347 - Pattaraju; Madaiah ; et al.	2012-02-23
Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing Grant 8,053,232 - Puttaraju , et al. November 8, 2	2011-11-08
Compositions And Methods For Generation Of Pluripotent Stem Cells App 20110263015 - D'Costa; Jenice G. ; et al.	2011-10-27
Regulated nucleic acid expression system Grant 8,043,611 - Chang , et al. October 25, 2	2011-10-25
Use Of Rna Trans-splicing For Antibody Gene Transfer And Antibody Polypeptide Production App 20110244519 - McGarrity; Gerard J. ; et al.	2011-10-06
Non-integrating Lenti/adeno-associated Virus Hybrid Vector System App 20110207226 - NI; Yajin ; et al.	2011-08-25
Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing Grant 7,968,334 - Puttaraju , et al. June 28, 2	2011-06-28
Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production Grant 7,879,321 - McGarrity , et al. February 1, 2	2011-02-01
Targeted trans-splicing of highly abundant transcripts for in vivo production of recombinant proteins Grant 7,871,795 - McGarrity , et al. January 18, 2	2011-01-18
Trans-splicing Mediated Photodynamic Therapy App 20090203143 - Mitchell; Lloyd G. ; et al.	2009-08-13
High-throughput Methods For Identifying Gene Function Using Lentiviral Vectors App 20090081682 - DROPULIC; Boro	2009-03-26
Autologous T Cell Manufacturing Processes App 20080274091 - Slepushkin; Vladimir ; et al.	2008-11-06
High-throughput methods for identifying gene function using lentiviral vectors Grant 7,427,474 - Dropulic September 23, 2	2008-09-23
Trans-splicing mediated photodynamic therapy Grant 7,399,753 - Mitchell , et al. July 15, 2	2008-07-15
Antibody Complexes App 20070036783 - Humeau; Laurent ; et al.	2007-02-15
Compositions and methods using lentivirus-based vectors for generating immune responses App 20060281128 - Lu; Xiaobin ; et al.	2006-12-14
Vector packaging cell line App 20060003452 - Humeau; Laurent ; et al.	2006-01-05
Regulated nucleic acid expression system Grant 6,835,568 - Chang , et al. December 28, 2	2004-12-28
Methods for stable transduction of cells with hiv-derived viral vectors Grant 6,627,442 - Humeau , et al. September 30, 2	2003-09-30

Company Registrations

NCAGE Code	4LLR1	VIRXSYS CORPORATION
CAGE Code	4LLR1	VIRXSYS CORPORATION
SEC	0001081596	VIRxSYS Corp of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.